TGF-β is associated with poor prognosis and promotes osteosarcoma progression via PI3K/Akt pathway activation.

Ma K, Zhang C, Li W

DOI: 10.1080/15384101.2020.1805552
Published: 2020 Sep
Container: Cell cycle (Georgetown, Tex.)
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/15384101.2020.1805552,
  title = {TGF-β is associated with poor prognosis and promotes osteosarcoma progression via PI3K/Akt pathway activation.},
  author = {Ma K and Zhang C and Li W},
  year = {2020},
  journal = {Cell cycle (Georgetown, Tex.)},
  doi = {10.1080/15384101.2020.1805552},
  url = {https://doi.org/10.1080/15384101.2020.1805552}
}

RIS

TY  - JOUR
TI  - TGF-β is associated with poor prognosis and promotes osteosarcoma progression via PI3K/Akt pathway activation.
AU  - Ma K
AU  - Zhang C
AU  - Li W
PY  - 2020
JO  - Cell cycle (Georgetown, Tex.)
DO  - 10.1080/15384101.2020.1805552
UR  - https://doi.org/10.1080/15384101.2020.1805552
ER  -

APA

K, M., C, Z., & W, L. (2020). TGF-β is associated with poor prognosis and promotes osteosarcoma progression via PI3K/Akt pathway activation.. Cell cycle (Georgetown, Tex.). https://doi.org/10.1080/15384101.2020.1805552

Source records

pubmed · retrieved 2026-09-26T00:40:15.906Z